Marked reduction of alcohol dehydrogenase in keratoconus corneal fibroblasts
- PMID: 19365573
- PMCID: PMC2666775
Marked reduction of alcohol dehydrogenase in keratoconus corneal fibroblasts
Abstract
Purpose: To identify differentially expressed genes in keratoconus (KC) corneal fibroblasts.
Methods: Stromal keratocytes (having a fibroblast morphology) from KC keratoplasty specimens and eye bank donor corneas were isolated and expanded using a serum containing medium. RNA was isolated from three KC fibroblast cultures and five eye bank donor cornea fibroblast cultures. The targets from the cultured fibroblasts were hybridized to the Affymetrix U133 Plus 2.0 microarrays. Western blot analyses of cell lysates were performed to examine protein levels of interest in the two groups. Protein levels of select differentially expressed genes were further examined by immunohistochemistry. Keratocyte staining of archived KC keratoplasty specimens were graded using a 0 to 3+ scale and compared to five archived whole globes having normal corneas as well as to 10 Fuchs' dystrophy keratoplasty specimens.
Results: Microarray analysis revealed up to a 212 fold reduction in the mRNA levels of alcohol dehydrogenase (class 1) beta polypeptide (ADH1B) in KC fibroblasts (p=0.04). Decreased alcohol dehydrogenase in KC fibroblasts was confirmed by western blot analysis of early passage primary keratocyte cell lysates. Immunohistochemistry using a monoclonal mouse immunoglobulin G (IgG) against human liver alcohol dehydrogenase revealed a dramatic difference in protein staining in the keratocytes of the KC group compared to the normal cornea group. Immunohistochemistry also showed decreased immunostaining against alcohol dehydrogenase in the KC stromal sections compared to those obtained from Fuchs' endothelial corneal dystrophy samples.
Conclusions: Decreased alcohol dehydrogenase in KC corneal fibroblasts represents a strong marker and possible mediator of keratoconus.
Figures




Similar articles
-
Expression of matrix metalloproteinases and their inhibitors in corneal stromal fibroblasts and keratocytes from healthy and keratoconus corneas.Graefes Arch Clin Exp Ophthalmol. 2025 Feb;263(2):467-475. doi: 10.1007/s00417-024-06601-y. Epub 2024 Aug 23. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 39177803 Free PMC article.
-
Downregulation of β-actin gene and human antigen R in human keratoconus.Invest Ophthalmol Vis Sci. 2012 Jun 26;53(7):4032-41. doi: 10.1167/iovs.11-9062. Invest Ophthalmol Vis Sci. 2012. PMID: 22562506 Free PMC article.
-
The presence of lysyl oxidase-like enzymes in human control and keratoconic corneas.Histol Histopathol. 2016 Jan;31(1):63-71. doi: 10.14670/HH-11-649. Epub 2015 Jul 28. Histol Histopathol. 2016. PMID: 26218558
-
Comorbidity of Keratoconus and Fuchs' Corneal Endothelial Dystrophy: A Review of the Literature.Ophthalmic Res. 2020;63(4):369-374. doi: 10.1159/000505579. Epub 2019 Dec 23. Ophthalmic Res. 2020. PMID: 31865313
-
Molecular and Histopathological Changes Associated with Keratoconus.Biomed Res Int. 2017;2017:7803029. doi: 10.1155/2017/7803029. Epub 2017 Jan 30. Biomed Res Int. 2017. PMID: 28251158 Free PMC article. Review.
Cited by
-
Genetics of keratoconus: where do we stand?J Ophthalmol. 2014;2014:641708. doi: 10.1155/2014/641708. Epub 2014 Aug 28. J Ophthalmol. 2014. PMID: 25254113 Free PMC article. Review.
-
Transcriptional profiling of corneal stromal cells derived from patients with keratoconus.Sci Rep. 2019 Aug 29;9(1):12567. doi: 10.1038/s41598-019-48983-8. Sci Rep. 2019. PMID: 31467338 Free PMC article.
-
Tear biomarkers for keratoconus.Eye Vis (Lond). 2016 Aug 4;3:19. doi: 10.1186/s40662-016-0051-9. eCollection 2016. Eye Vis (Lond). 2016. PMID: 27493978 Free PMC article. Review.
-
Tissue-Derived Biological Particles Restore Cornea Properties in an Enzyme-Mediated Corneal Ectatic Model.Bioengineering (Basel). 2019 Sep 27;6(4):90. doi: 10.3390/bioengineering6040090. Bioengineering (Basel). 2019. PMID: 31569699 Free PMC article.
-
Systematically Displaying the Pathogenesis of Keratoconus via Multi-Level Related Gene Enrichment-Based Review.Front Med (Lausanne). 2022 Jan 24;8:770138. doi: 10.3389/fmed.2021.770138. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35141241 Free PMC article.
References
-
- Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297–319. - PubMed
-
- Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620–7. - PubMed
-
- Sawaguchi S, Yue BY, Sugar J, Gilboy JE. Lysosomal enzyme abnormalities in keratoconus. Arch Ophthalmol. 1989;107:1507–10. - PubMed
-
- Sawaguchi S, Twining SS, Yue BY, Wilson PM, Sugar J, Chan SK. Alpha-1 proteinase inhibitor levels in keratoconus. Exp Eye Res. 1990;50:549–54. - PubMed
-
- Opbroek A, Kenney MC, Brown D. Characterization of a human corneal metalloproteinase inhibitor (TIMP-1). Curr Eye Res. 1993;12:877–83. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources